Company Filing History:
1 out of 1,500 
1 out of 24 
1 out of 1 Years Active: 2015-2022
Title: Jason Tierney: Innovator in Pharmaceutical Compounds
Introduction
Jason Tierney is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues. With a total of 3 patents, his work focuses on innovative solutions for cardiovascular diseases and sepsis.
Latest Patents
Among his latest patents, one is titled "PCSK9 inhibitors and methods of use thereof." This invention relates to novel heteroaryl compounds of Formula (I) and pharmaceutical preparations thereof. The invention further details methods for treating or preventing cardiovascular diseases, as well as methods for treating sepsis or septic shock using the novel heterocyclic compounds disclosed. Another significant patent is "ASK1 inhibiting pyrrolopyrimidine derivatives," which pertains to pyrrolopyrimidine derivatives of formula (I) and their use as pharmaceuticals.
Career Highlights
Throughout his career, Jason Tierney has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Convergence Pharmaceuticals Limited. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Jason has collaborated with notable colleagues, including David Witty and David Norton, which has further enriched his professional journey and contributed to his innovative work.
Conclusion
Jason Tierney stands out as a dedicated inventor whose work in pharmaceutical compounds has the potential to significantly impact healthcare. His innovative patents and collaborations reflect his commitment to advancing medical science.